iECURE

Biotechnology Research • Philadelphia, Pennsylvania, United States • 21-50 Employees

Company overview

Headquarters	Philadelphia, Pennsylvania, United States
Phone number	+12025050612
Website	iecure.com
SIC	809
Founded	2020
Employees	21-50
Socials

Key Contacts at iECURE

Joseph Truitt

Chief Executive Officer

Patricia Ward

Senior Director, Quality & Compliance

Jane Fisher

Senior Director, Analytical

Karen Kuhn

Sr. Director Clinical Operations

Mike Burnham

Senior Director Manufacturing Sciences & Technology Lead

Jeff Kopesky

Field Medical Director, West

Dave Lecher

Senior Director Of Supply Chain

Brian Didonato

Member Board Of Directors

Thomas White

Lead Field Medical Director

Michelle Miller

Senior Director Regulatory Affairs

iECURE Email Formats

iECURE uses 3 email formats. The most common is {first initial}{last name} (e.g., jdoe@iecure.com), used 52.8% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@iecure.com	52.8%
{first name}{last name}	johndoe@iecure.com	44.4%
{last name}{last name}	doedoe@iecure.com	2.8%

About iECURE

iECURE is a clinical-stage genome editing company focused on delivering cures and transforming the lives of patients with devastating liver disorders, utilizing new advancements in genetic medicine. We believe our in vivo targeted gene insertion approach has the potential to restore the function of a dysfunctional gene, regardless of variant, by inserting a functional copy of that gene to provide durable gene expression and long-term, potentially curative, therapeutic benefit. The company is advancing a pipeline of genetic medicines, led by ECUR-506, an investigational targeted gene insertion therapy in clinical development for the treatment of neonatal onset ornithine transcarbamylase (OTC) deficiency. iECURE is proud to be recognized as one of the Philadelphia Business Journal’s “Best Places to Work” for the second year in a row and was named to Fierce Biotech’s “Fierce 15” in 2024. We are headquartered in Blue Bell, PA.

iECURE revenue & valuation

Annual revenue	$2,000,000
Revenue per employee	$53,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$6,400,000
Total funding	$65,000,000